Industry round-up: Aurora Imaging, Capital Fund, Cedara, Imperial Innovations, MEDecision

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Aurora Imaging Technology Inc. named recognized scientist Paul Ching-Wu Chu, to its advisory board. Chu is the current president of Hong Kong University of Science and Technology, and T. L. L. Temple chair of science, professor of physics and executive director of the Texas Center for Superconductivity at the University of Houston.

A distinguished scientist, in 1987, Chu and his team discovered stable superconductivity above the boiling point of liquid nitrogen, a breakthrough which opened the door to subsequent developments of an entire field of high temperature superconductivity. Chu has won numerous scientific awards, including the World Congress on Superconductivity’s Award for Excellence, the National Medal of Science of the U.S., the Bernd Matthias Prize, and the John Fritz Medal.

Cedara Software has signed an agreement with Biotronics3D Ltd. that grants the London-based software company a license to market C4 enabled versions of its 3Dnet Suite family of 3D visualization software. Under the agreement, Biotronics3D will distribute C4 enabled Biotronics3D applications to OEMs that are adopting the C4 framework and other C4 clinical application modules from Cedara and its other partners. The C4 (Cedara Clinical Control Center) platform is a software framework that enables a host application to obtain plug-and-play access to a diverse array of clinical application modules after completing a one-time integration. C4 enabled plug-in modules can be launched from any C4 enabled host.

Imperial Innovations Group plc in the United Kingdom, a technology commercialization and investment company, along with The Capital Fund, a regional venture capital fund based in London, have together invested to co-lead an investment round of $4.8 million into IXICO Limited, a provider of image analysis solutions for the pharmaceutical industry. The fundraising will enable the company to sustain its growth, build value, and reinforce the company’s balance sheet. 

Founded in 2004, using technology from Imperial College London and King’s College London, IXICO provides state-of-the-art image analysis solutions for pre-clinical and clinical trials. The company’s products and services combine world-leading image acquisition expertise with sophisticated computer algorithms devised by its employees and four scientific founders. 

MEDecision is providing Collaborative Care Management technologies to Lovelace Health Plan of New Mexico, allowing the insurer to optimize healthcare management and delivery across its network of more than 190,000 members. Lovelace Health Plan has contracted with MEDecision for its advanced medical management, data gathering and analytics, and clinical data exchange tools, which are designed to identify patients and populations that would benefit from care management, and health and wellness intervention.

The facility has also licensed the MEDecision Patient Clinical Summary, a clinical, payer-based electronic health record.